BluTest Expands UKAS Accreditation to Include EN 16777 Surface Virucidal Efficacy Testing

We’re excited to share that BluTest – A Tentamus Company has officially expanded its UKAS accreditation to include EN 16777, a key surface virucidal efficacy test for non-porous surfaces, commonly required in medical, clinical, and healthcare environments.

This latest accreditation marks BluTest's second scope extension in 2025, further enhancing our ability to support clients with regulatory testing services that meet the strict requirements of the Biocidal Products Regulation (BPR).

What is EN 16777?

EN 16777 is a quantitative, non-porous surface test designed to assess the virucidal activity of chemical disinfectants. It plays a crucial role in demonstrating product efficacy for surface disinfection in high-risk settings—an essential part of BPR submissions and product approval processes.

Why UKAS Accreditation Is Important To Us And Our Clients

By achieving UKAS-accredited status for EN 16777, BluTest Laboratories can now offer clients fully accredited test reports—adding value to regulatory submissions, product development, and disinfectant product launches. Accreditation provides assurance that the method is carried out under strict quality standards, helping manufacturers meet industry expectations and regulatory demands with confidence.

Accredited Virucidal Efficacy Testing for BPR Compliance

Our expanded scope strengthens BluTest’s reputation as a trusted provider of biocide testing and efficacy studies for a wide range of disinfectant products, including those intended for use in hospitals, clinics, and public health settings. We continue to support customers through the full testing journey—from method selection to BPR dossier support.

For more information, please feel free to contact us via our contact form.